| |
| |
|
| Insider
Information: |
Larson Brent L |
| Relationship: |
EVP, CFO, Treas & Secy |
| City: |
Dublin |
| State: |
OH |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
222,237 |
|
|
Indirect Shares
|
98,081 |
|
|
| Direct
Value |
$32,313 |
|
|
|
Indirect Value
|
$14,261 |
|
|
| Total
Shares |
320,318 |
|
|
| Total
Value |
$46,574 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Navidea Biopharmaceuticals |
NAVB |
EVP, CFO, Treas & Secy |
2015-12-01 |
222,237 |
2015-04-01 |
98,081 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas & Secy |
• – – |
2015-12-01 |
4 |
AS |
$1.50 |
$18,750 |
D/D |
(12,500) |
222,237 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas & Secy |
• – – |
2015-11-02 |
4 |
AS |
$1.98 |
$24,750 |
D/D |
(12,500) |
234,737 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas & Secy |
• – – |
2015-10-01 |
4 |
AS |
$2.27 |
$28,375 |
D/D |
(12,500) |
247,237 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas and Secy |
• – – |
2015-09-01 |
4 |
AS |
$1.88 |
$23,516 |
D/D |
(12,500) |
259,737 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas and Secy |
• – – |
2015-08-03 |
4 |
AS |
$1.71 |
$21,330 |
D/D |
(12,500) |
272,237 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas and Secy |
• – – |
2015-07-01 |
4 |
AS |
$1.61 |
$20,134 |
D/D |
(12,500) |
284,737 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas and Secy |
• – – |
2015-06-01 |
4 |
AS |
$1.24 |
$15,538 |
D/D |
(12,500) |
297,237 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas and Secy |
• – – |
2015-05-01 |
4 |
AS |
$1.33 |
$16,625 |
D/D |
(12,500) |
309,737 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas and Secy |
• – – |
2015-04-01 |
4 |
AS |
$1.58 |
$31,550 |
D/D |
(20,000) |
322,237 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas and Secy |
• – – |
2014-12-10 |
4 |
D |
$1.31 |
$35,301 |
D/D |
(26,947) |
342,237 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas and Secy |
• – – |
2014-12-10 |
4 |
OE |
$0.39 |
$19,500 |
D/D |
50,000 |
369,184 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas & Secy |
• • – |
2014-03-10 |
4 |
S |
$1.96 |
$81,340 |
D/D |
(41,500) |
319,184 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas & Secy |
• • – |
2014-03-10 |
4 |
D |
$1.99 |
$24,501 |
D/D |
(12,312) |
360,684 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas & Secy |
• • – |
2014-03-10 |
4 |
OE |
$0.49 |
$24,500 |
D/D |
50,000 |
372,996 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas & Secy |
• • – |
2014-01-07 |
4 |
D |
$1.93 |
$66,214 |
D/D |
(34,308) |
322,996 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas & Secy |
• • – |
2014-01-07 |
4 |
OE |
$0.30 |
$21,000 |
D/D |
70,000 |
357,304 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
EVP, CFO, Treas & Secy |
• • – |
2013-11-08 |
4 |
B |
$1.39 |
$6,950 |
D/D |
5,000 |
287,304 |
2.74 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
SVP, CFO, Treas & Secy |
• • – |
2013-03-13 |
4 |
D |
$3.16 |
$135,314 |
D/D |
(42,821) |
282,304 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
SVP, CFO, Treas & Secy |
• • – |
2013-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
325,125 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
SVP, CFO, Treas & Secy |
• – – |
2012-04-20 |
4 |
D |
$2.69 |
$40,350 |
D/D |
(15,000) |
200,125 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
VP Finance and CFO |
• – – |
2010-12-14 |
4 |
OE |
$0.41 |
$24,600 |
D/D |
60,000 |
183,292 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
VP Finance and CFO |
• – – |
2010-12-14 |
4 |
D |
$1.97 |
$55,909 |
D/D |
(28,380) |
154,912 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
VP Finance and CFO |
• – – |
2009-10-22 |
4 |
D |
$1.20 |
$44,050 |
D/D |
(36,708) |
123,292 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
VP Finance and CFO |
• – – |
2009-10-22 |
4 |
OE |
$0.50 |
$30,000 |
D/D |
60,000 |
160,000 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
VP Finance and CFO |
• – – |
2006-05-12 |
4 |
B |
$0.27 |
$1,215 |
D/D |
4,500 |
100,000 |
2.66 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
